BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18551608)

  • 1. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.
    Shao Y; Lo CM; Ling CC; Liu XB; Ng KT; Chu AC; Ma YY; Li CX; Fan ST; Man K
    Cancer Lett; 2014 Dec; 355(2):264-72. PubMed ID: 25301451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
    Shimabukuro-Vornhagen A; Schlößer HA; Gryschok L; Malcher J; Wennhold K; Garcia-Marquez M; Herbold T; Neuhaus LS; Becker HJ; Fiedler A; Scherwitz P; Koslowsky T; Hake R; Stippel DL; Hölscher AH; Eidt S; Hallek M; Theurich S; von Bergwelt-Baildon MS
    Oncotarget; 2014 Jul; 5(13):4651-64. PubMed ID: 25026291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
    Gedaly R; Angulo P; Chen C; Creasy KT; Spear BT; Hundley J; Daily MF; Shah M; Evers BM
    Anticancer Res; 2012 Jul; 32(7):2531-6. PubMed ID: 22753710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased percentage of B cells in patients with more advanced hepatocellular carcinoma.
    Lin JC; Shih YL; Chien PJ; Liu CL; Lee JJ; Liu TP; Ko WC; Shih CM
    Hum Immunol; 2010 Jan; 71(1):58-62. PubMed ID: 19819282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.
    Li Q; Dong Y; Pan Y; Tang H; Li D
    Front Immunol; 2021; 12():634559. PubMed ID: 33868256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review.
    Meng J; Pan H; Li X; Liu T; Liu Z; Li Q; Xiao Y; Liu X; Wu G; Zhu F; Zhang L
    Front Oncol; 2019; 9():1367. PubMed ID: 31921632
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.
    Tajiri H; Sugimachi K; Kinjo N; Ikebe M; Tanaka J; Tanaka K; Tsukamoto S; Mii S; Kajiwara E; Shimokama T; Higashi H
    Surg Today; 2014 Jan; 44(1):188-91. PubMed ID: 23404391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma infiltrated with non-Hodgkin's lymphoma: report of a case.
    Utsunomiya T; Okamoto M; Tsujita E; Yamamoto M; Tsutsui S; Fujihara M; Ishida T
    Surg Today; 2009; 39(11):1010-2. PubMed ID: 19882328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
    Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
    J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.
    Vukotic R; Gramenzi A; Vitale G; Cursaro C; Serra C; Biselli M; Scuteri A; Andreone P; Bernardi M
    Liver Int; 2008 Mar; 28(3):407-11. PubMed ID: 17900241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):122-8. PubMed ID: 16706823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C.
    Kubo S; Nishiguchi S; Tamori A; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Kuroki T; Kinoshita H
    Hepatogastroenterology; 2000; 47(34):1100-2. PubMed ID: 11020887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.